Achieving postprandial glucose control with lixisenatide improves glycemic control in patients with type 2 diabetes on basal insulin: a post-hoc analysis of pooled data

被引：3
|
作者：
Jaime A. Davidson
William Stager
Sachin Paranjape
Rachele Berria
Lawrence A. Leiter
机构：
[1] The University of Texas Southwestern Medical Center,Department of Internal Medicine, Touchstone Diabetes Center
[2] Sanofi US,Li Ka Shing Knowledge Institute
[3] Inc,undefined
[4] St Michael’s Hospital,undefined
[5] University of Toronto,undefined
来源：
Clinical Diabetes and Endocrinology | / 6卷 / 1期
关键词：
Type 2 diabetes; Lixisenatide; Glucagon-like peptide-1 receptor; Post-prandial glucose; Glycemic targets;
D O I：
10.1186/s40842-019-0088-5
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [41] Optimal glycemic control in type 2 diabetes mellitus - Fasting and postprandial glucose in context
    Abrahamson, MJ
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (05) : 486 - 491
  • [42] Impact of improving postprandial glycemic control with intensifying insulin therapy in type 2 diabetes
    Yacoub, Tamer
    [J]. POSTGRADUATE MEDICINE, 2017, 129 (08) : 791 - 800
  • [43] Lixisenatide improves glycemic outcomes of Japanese patients with type 2 diabetes: a meta-analysis
    Seino, Hiroaki
    Onishi, Yukiko
    Naito, Yusuke
    Komatsu, Mitsuhisa
    [J]. DIABETOLOGY & METABOLIC SYNDROME, 2016, 8
  • [44] Effect of Continuous Glucose Monitoring on Glycemic Control in Patients With Type 2 Diabetes Treated With Basal Insulin A Randomized Clinical Trial
    Martens, Thomas
    Beck, Roy W.
    Bailey, Ryan
    Ruedy, Katrina J.
    Calhoun, Peter
    Peters, Anne L.
    Pop-Busui, Rodica
    Philis-Tsimikas, Athena
    Bao, Shichun
    Umpierrez, Guillermo
    Davis, Georgia
    Kruger, Davida
    Bhargava, Anuj
    Young, Laura
    McGill, Janet B.
    Aleppo, Grazia
    Nguyen, Quang T.
    Orozco, Ian
    Biggs, William
    Lucas, K. Jean
    Polonsky, William H.
    Buse, John B.
    Price, David
    Bergenstal, Richard M.
    Group, Mobile Study
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2021, 325 (22): : 2262 - 2272
  • [45] ANALYSIS OF GLYCEMIC CONTROL AND MICROVASCULAR COMPLICATIONS IN TYPE 2 DIABETES AND CONTROL OF GLUCOSE
    Shaikh, Ayesha Tahsin
    Sajjad, Rabia
    Shahid, Ayesha
    [J]. INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (08): : 7998 - 8001
  • [46] Physiologic insulin replacement in type 2 diabetes - Optimizing postprandial glucose control
    Robertson, Carolyn
    [J]. DIABETES EDUCATOR, 2006, 32 (03): : 423 - 432
  • [47] Insulin glargine improves glycemic control assessed by subcutaneous continuous glucose monitoring in patients with type 1 diabetes
    Delles, C
    Janisch, HD
    [J]. DIABETES, 2004, 53 : A461 - A461
  • [48] Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
    Kostev, Karel
    Dippel, Franz W.
    Rathmann, Wolfgang
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2015, 8 : 45 - 48
  • [49] Pramlintide improved glycemic control and reduced weight in patients with type 2 diabetes using basal insulin
    Riddle, Matthew
    Frias, Juan
    Zhang, Bei
    Maier, Holly
    Brown, Carl
    Lutz, Karen
    Kolterman, Orville
    [J]. DIABETES CARE, 2007, 30 (11) : 2794 - 2799
  • [50] Early Hospitalization for Diabetes Care Improves Glycemic Control in Patients with Type 2 Diabetes Reserved Insulin Secretion
    Ikeda, Daisuke
    [J]. DIABETES, 2018, 67
12345